Not available
Quote | Alimera Sciences Inc. (NASDAQ:ALIM)
Last: | $3.57 |
---|---|
Change Percent: | 4.0% |
Open: | $3.6 |
Close: | $3.57 |
High: | $3.84 |
Low: | $3.54 |
Volume: | 57,870 |
Last Trade Date Time: | 05/07/2024 03:00:00 am |
News | Alimera Sciences Inc. (NASDAQ:ALIM)
ATLANTA, May 07, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announced today it ...
ATLANTA, April 30, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces today that it will repo...
Message Board Posts | Alimera Sciences Inc. (NASDAQ:ALIM)
Subject | By | Source | When |
---|---|---|---|
agreed | The Night Stalker | investorshub | 05/18/2023 2:32:25 PM |
$ALIM I got in for a play | MiamiGent | investorshub | 05/18/2023 1:45:59 PM |
Alimera Acquires U.S. Commercial Rights to YUTIQ | subslover | investorshub | 05/18/2023 12:24:59 PM |
$ALIM best news of the day | whytestocks | investorshub | 05/17/2023 10:09:44 PM |
is it bear time? Or do we go bull? | mick | investorshub | 05/17/2023 8:52:48 AM |
News, Short Squeeze, Breakout and More Instantly...
Alimera Sciences Inc. Company Name:
ALIM Stock Symbol:
NASDAQ Market:
Alimera Sciences Inc. Website:
ATLANTA, May 07, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announced today it ...
ATLANTA, April 30, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces today that it will repo...
ATLANTA, March 20, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera” or the “Company”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health, and maintaining better...